Costotransverse Foramen Block Versus Thoracic Paravertebral Block in Thoracotomy for Lung Cancer
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorNational Cancer Institute, Egypt
About this trial
This study aims to compare the costotransverse foramen block (CTFB) with thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer.
Eligibility criteria
Qualifiers
Age > 18 years and ≤ 65 years old.
American Society of Anesthesiologists (ASA) physical status II-III.
Body mass index 18-35 kg/m2.
Patients scheduled for thoracotomies for lung cancer.
Disqualifiers
Patient refusal.
History of sensitivity to local anesthetics.
History of psychological disorders.
Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.
Trial design
Treatments tested in this trial
- Costotransverse foramen block
- Thoracic paravertebral plane block
Treatment groups
70 Participants
are divided into 2 treatment groupsLocations
1Cairo University12613, Cairo Egypt
Sponsors and collaborators
National Cancer Institute, Egypt
Lead sponsor
Source ClinicalTrials.gov